Prosecution Insights
Last updated: April 19, 2026

Chongqing Claruvis Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18547979 MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF EIX, EMILY FAY 1653 Non-Final OA Aug 25, 2023
18547850 PREPARATION METHOD FOR MODIFIED TOXIN POLYPEPTIDE EIX, EMILY FAY 1653 Final Rejection Aug 24, 2023

Managing Chongqing Claruvis Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month